Lancet

Papers
(The TQCC of Lancet is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-07-01 to 2026-07-01.)
ArticleCitations
Donald Bernard Longmore1148
Interpreting COVID-19 data from China: a call for caution996
Human rights considerations are key when choosing a conference location886
Establishing equitable partnerships between the Global North and Global South884
The acknowledgment of death755
Miriam Mutebi: transforming breast cancer care in Africa735
Tonsillectomy for recurrent tonsillitis: the NATTINA trial705
Merrill Singer597
Atosiban and managing women in preterm labour576
Hearing intervention and cognitive decline: the ACHIEVE trial504
Political courage needed to prevent the next pandemic504
Thinking outside of the tin box484
Hypochondria, the ghost at medicine's feast482
May Edward Chinn: pioneer of early cancer detection468
Ronald Duncan Bradley452
Israel border closure denying health care to Gazans379
Considerations for the CHH–Lancet Commission on Health, Conflict, and Forced Displacement368
The 2024 Lasker Awards358
CAR T-cell perspectives in lupus – Authors' reply357
“I'm losing faith in everything”: a qualitative study to understand barriers to accessing suitable mental health support for children and young people in Wales347
Lower respiratory tract infections in early childhood333
Tackling heroin use in Mozambique333
A decolonised Commission agenda: the missing ingredients331
Protecting children from racism: urgent health system actions303
Health at stake in Kenya elections291
The Peer Education Project to improve mental health literacy in secondary school students in England: a qualitative realist evaluation273
Sackler money to go towards reducing overdose deaths246
床前孝子233
Offline: “I have no place to go”219
Anthony Bryceson198
Annabel Sowemimo: countering inequities in health care193
US plan to shield science from “inappropriate influence”183
Perilous two-tier COVID-19 global vaccine roll-out179
Orbital atherectomy for stent implantation: the ECLIPSE trial – Authors' reply177
The road ahead for immediate kangaroo mother care in resource-constrained health systems175
Protein provision during critical illness171
To keep health as a unifying force, we must put resources into tackling health misinformation and disinformation163
Changing gloves and switching instruments to decrease surgical site infection in abdominal surgery154
Morphine for Gaza? Limits of care during genocidal violence153
Moving past the COVID-19 emergency in the USA145
Increasing humanitarian concerns for 2023139
On the quantification of military violence in Gaza138
Pandemics and the tourism industry: who is in control?137
Calvarium indentations in multiple myeloma and CAR T-cell therapy136
Interferon shrinks spleen in pregnant patient with myeloproliferative neoplasm131
Nafis Sadik131
Offline: What have we done to medical students?127
Prominent skin folds of the scalp provide a superficial clue in acromegaly124
Nigeria: health as a political prerequisite117
Visa bureaucracy causing GPs to leave the UK117
A fair day's wage for a fair day's work113
Offline: Changing the argument for health107
Anatomy teaching, dissection, and dignity of the dead105
High-dose corticosteroid therapy in COVID-19: the RECOVERY trial104
Imagining alternative paths for WHO 75 years in103
Remote haemodynamic monitoring in patients with heart failure – Authors' reply99
Gaining MOMENTUM against anaemic myelofibrosis98
Routine immunisations: reversing the decline89
Human rights and health: a story of justice, hope, and resilience87
Ophira Ginsburg: educating and empowering women with cancer85
Lowitja O'Donoghue82
Associations between parental smoking and teenage alcohol and drug use in the Growing Up in Ireland cohort study: a longitudinal observational study81
High-dose corticosteroid therapy in COVID-19: the RECOVERY trial – Authors' reply78
Treatment of vulnerable atherosclerotic plaques: the PREVENT trial77
Türkiye rocked by newborn care scandal72
High-dose dual-antibiotic loaded bone cement in patients undergoing hemiarthroplasty70
Tom Beauchamp69
Iscalimab 600 mg: justified or excessive? – Authors' reply62
A taste of your own medicine: the experience of a transplant62
Prioritising maternal health must include care before pregnancy62
Offline: The death of globalism (part 2)59
Strikes58
Long COVID: which symptoms can be attributed to SARS-CoV-2 infection?58
Mpox: the need for a coordinated international response57
Breaking dependency: strengthening the global tuberculosis response in the face of USAID cuts56
A new drug for rare diseases: pozelimab for CHAPLE disease53
Primary health-care practices for deaf children should include early incorporation of a signed language52
A new era for Africa CDC51
Primary health care on the ballot in Australian election50
Australia to introduce sweeping e-cigarette regulations48
Department of Error47
Department of Error45
Department of Error43
Department of Error41
Retraction: The first tissue-engineered airway transplantation: 5-year follow-up results40
Department of Error40
Department of Error40
Impact of anti-immigration measures on health35
Efgartigimod for primary immune thrombocytopenia: the ADVANCE IV trial – Authors' reply35
Beverly Malone: valuing diversity in nursing35
Legal accountability for climate change35
Offline: The unavoidable reckoning34
Preventing cancer: the only way forward33
Emergence of vaccine-derived poliovirus in high-income settings in the absence of oral polio vaccine use33
Treatment of MSSA bacteraemia: a call for a personalised approach32
The dawn of immunotherapy in mismatch repair proficient colorectal cancer31
Health care under Milei31
The rise of China's research: a global opportunity30
Pivotal points in the science of dementia risk reduction30
Mpox in Kenya29
Peace: more than an end to war29
Department of Error27
Uniting academies of medicine on climate and health27
Delayed immune tolerance through donor haematopoietic stem cell infusion 14 months after kidney transplantation27
Improving children's lives—the case for universality26
Brazil to start widespread dengue vaccinations26
From innovation to impact in cardiovascular disease25
Autosomal dominant polycystic kidney disease24
Racial inequities in homicide rates: Black women in the USA24
Offline: Political declarations—clichés and lies23
Offline: Meditations of melancholy23
Immediate versus delayed sequential bilateral cataract surgery23
IMbrave050: the first step towards adjuvant therapy in hepatocellular carcinoma22
South Korean doctors threaten mass resignation22
Can the FDA fulfil its mission with a smaller workforce?22
Fluid retention and heart failure in the PRECISION trial – Authors' reply22
Pembrolizumab for locally advanced cervical cancer22
Moderna stalls on African vaccine manufacturing plans22
Why Ukraine's energy insecurity is a maternal health crisis22
Malaria vaccines: a test for global health21
A just transition for antimicrobial resistance: planning for an equitable and sustainable future with antimicrobial resistance21
“It's not about us anymore”: after the Le Scouarnec case21
Mortality during migration through the Darién Gap in Panama in 2018–2220
Efficacy of once-daily, high-dose, oral insulin immunotherapy in children genetically at risk for type 1 diabetes (POInT): a European, randomised, placebo-controlled, primary prevention trial19
Colonoscopy versus faecal immunochemical testing in COLONPREV18
An SMS and animated video intervention to increase uptake of breast cancer screening: a randomised controlled trial18
Politicised threats to science endanger global health and humanity17
Realising transformative change in adolescent health and wellbeing: a second Lancet Commission17
Percutaneous transcatheter valve replacement in individuals with mitral regurgitation unsuitable for surgery or transcatheter edge-to-edge repair: a prospective, multicountry, single-arm trial17
Feasibility of interrupting the transmission of soil-transmitted helminths: the DeWorm3 community cluster-randomised controlled trial in Benin, India, and Malawi15
An age of uncertainty: mental health in young people14
Hypertension control: a South Korean success story14
Anna Gilmore: confronting the commercial determinants of health14
Resurgence of cholera amidst ongoing war in Sudan14
Challenges in mitigating weight regain with incretin-based therapy14
Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL)14
Childhood epilepsy14
Targeting CD40 with dapirolizumab pegol: a new treatment for systemic lupus erythematosus14
Hypertrophic cardiomyopathy secondary to hydroxychloroquine toxicity in a patient with rheumatoid arthritis13
Natural or artificial menstrual cycle for frozen embryo transfer13
Visualising facial distortions in prosopometamorphopsia13
Regional action needed to halt antimalarial drug resistance in Africa13
The injustice of tuberculosis13
Does TRIANGLE take down transplantation in mantle cell lymphoma?12
Use the remaining carbon budget wisely for health equity and climate justice12
Department of Error12
Impact of the COVID-19 pandemic on delayed care of cardiovascular diseases in Europe: a systematic review12
Outcome measure limitations in the SCIENCE trial12
The health dimensions of violence in Palestine: a call to prevent genocide12
Sanctions and the right to health in post-Assad Syria12
TRiP(cast) score and thrombosis risk for lower limb immobilisation – Authors' reply12
Budesonide–formoterol versus salbutamol as reliever therapy in children with mild asthma (CARE): a 52-week, open-label, multicentre, superiority, randomised controlled trial11
Key questions regarding the SYMPLICITY HTN-3 trial11
Threat level in the Gaza Strip: fatalities per 1000 person-years11
Repeat placental growth factor-based testing in women with suspected preterm pre-eclampsia (PARROT-2): a multicentre, parallel-group, superiority, randomised controlled trial10
Efficacy and safety of intravenous nerinetide initiated by paramedics in the field for acute cerebral ischaemia within 3 h of symptom onset (FRONTIER): a phase 2, multicentre, randomised, double-blind10
Updated trends in the global prevalence and burden of mental disorders, 1990–2023: a systematic analysis for the Global Burden of Disease Study 202310
Burden of bacterial antimicrobial resistance in low-income and middle-income countries avertible by existing interventions: an evidence review and modelling analysis10
Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial10
WHO and Africa CDC declare the 2026 Ebola disease outbreak a public health emergency10
Implementation of adaptation to climate change in public health in Europe: qualitative thematic analysis10
Epidemiology of cardiometabolic multiple long-term conditions10
From disappointment to despair: USAID cuts to Myanmar's HIV services10
Enpatoran, a Toll-like receptor 7/8 inhibitor, in moderate-to-severe systemic lupus erythematosus: findings from Cohort B of a multicentre, international, double-blind, placebo-controlled dose-finding10
Offline: Ten lessons for women's and children's health9
Patellar resurfacing in total knee replacement: 20-year clinical and economic results of a large multicentre, randomised controlled trial in the UK9
WHO EMRO's initiative on economic sanctions: delayed but promising9
Refiloe Masekela: building access to care for childhood lung disease9
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China9
Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial9
Prademagene zamikeracel for recessive dystrophic epidermolysis bullosa wounds (VIITAL): a two-centre, randomised, open-label, intrapatient-controlled phase 3 trial9
Haemophilia9
Deaths potentially averted by small changes in physical activity and sedentary time: an individual participant data meta-analysis of prospective cohort studies8
Effectiveness and cost-effectiveness of an individualised, progressive walking and education intervention for the prevention of low back pain recurrence in Australia (WalkBack): a randomised controlle8
Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes8
Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials8
Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised control8
Nigeria's National Mental Health Act 2021: any challenges ahead?8
Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches8
Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study8
Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in chronic limb-threatening ischaemia (SWEDEPAD 1): a multicentre, participant-masked, registry-based, random8
Who pays and what pays off in sexual and reproductive health? A review of the cost and cost-effectiveness of interventions and implications for future funding and markets8
Indomethacin with or without prophylactic pancreatic stent placement to prevent pancreatitis after ERCP: a randomised non-inferiority trial8
Shakuntala Thilsted: shifting our approach to food systems7
Assessing adherence to Government's sugar, salt, and calorie reduction targets of the top 20 UK restaurants' menus in 2024: a cross-sectional study7
Policy and legislative approaches to address the social determinants of violence against children: an umbrella review.7
CAR T-cell therapy for patients with relapsed or refractory marginal zone lymphoma7
Mechanical circulatory support for cardiogenic shock7
Optimal usage of antibacterial sutures for wound closure in clinical trials addressing SSI – Authors' response7
The pathogenesis of Parkinson's disease7
Public health and gun violence7
Warnings over misuse of psychiatry in Russia7
Global HIV targets: a roadmap to 2030 and beyond7
Assessing worldwide trends of underweight and obesity7
Timing of cardiac surgery and anticoagulants after acute ischaemic stroke7
Racism and the health system7
Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study7
Co-production of a stakeholder workshop to inform multimorbidity prevention research: working with public contributors to ask the right questions (the MELD-B experience)7
Opioids for back and neck pain: the OPAL trial7
Irrigation efficacy in CSDH surgery: the FINISH trial – Authors' reply7
Human epidermal growth factor receptor 2-positive metastatic gastric cancer in complete sustained remission with trastuzumab7
Unanswered questions from the IRONMAN trial7
To what extent does time spent on social media influence adolescent use of cigarettes and e-cigarettes: a longitudinal analysis of the UK Millennium Cohort Study7
Endovascular thrombectomy for acute ischaemic stroke: the TENSION trial6
Lowering LDL cholesterol in clinical practice: time for change?6
The USA and the plight of children in a humanitarian crisis6
USA–China tariffs on pharmaceuticals affect global health equity6
Private actors and governance for planetary health equity6
Error in NHS England's BMI calculator and daily calorie recommendations6
Why aren't the Republicans talking about health?6
Thomas Fogarty6
Offline: No dark sarcasm in the classroom6
Drug-coated balloon angioplasty and stenting for coronary artery lesions6
Offline: “My brothers and sisters in Israel and Palestine”6
Opening the door to widespread iPSC-derived regenerative therapy for corneal epithelial opacity6
Seizure-induced apnoea and the risk of sudden unexpected death in epilepsy6
“Even worse than fentanyls”: nitazenes in the USA6
0.33663296699524